4.6 Article Proceedings Paper

Medical and economic outcomes of point-of-care testing

期刊

CLINICAL CHEMISTRY AND LABORATORY MEDICINE
卷 40, 期 3, 页码 246-251

出版社

WALTER DE GRUYTER GMBH
DOI: 10.1515/CCLM.2002.040

关键词

point-of-care testing; clinical and economic outcomes; surrogate markers; cost benefit; compliance with therapy

向作者/读者索取更多资源

Pointofcare testing is concerned with the immediacy of response, primarily because of the need to act in a lifethreatening crisis or to provide counsel in the ongoing management of a chronic disease. There are both clinical, operational and economic benefits that can accrue from this testing modality which may be observed from several perspectives the patient, the clinician, the healthcare provider, the healthcare purchaser and society. Thus pointofcare testing can improve the management of chronic diseases such as diabetes, compromised coagulation status and epilepsy both in terms of optimisation of, and compliance with, therapy. There are also lifethreatening crises that can be averted by rapid provision of test results. Each of these scenarios can lead to more efficient use of healthcare resources.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据